Search
BioCryst Pharmaceuticals Inc
BCRXAdd to Watchlist
8.980USD
-0.260-2.81%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.28BMarket Cap
LossP/E TTM
BioCryst Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of BioCryst Pharmaceuticals Inc is 8.70, ranking 66 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.21, which is -250.91% below the recent high of 7.87 and -3407.78% above the recent low of -182.87.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.